Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis
MetadataShow full item record
© 2016 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology,ABSTRACT: This study aimed to provide evidence on whether children at risk of gastrointestinal inflammation have increased measurements of faecal calprotectin (FC). Faecal calprotectin was measured in 232 children; 55 children (n?=?11 treatment naïve) with juvenile idiopathic arthritis (JIA), 63 with coeliac disease (CD); 17 with new diagnosis before and after treatment on gluten free diet and 114 controls. None of the treatment-naive children with JIA had raised FC. Four JIA patients on treatment had a raised FC but in all cases a repeat test was normal. In newly diagnosed CD patients, the median (IQR) FC was higher 36.4 (26–61) than in controls 25.0 (23–41) mg/kg (p?=?0.045) but this significantly decreased 25 (25–25) mg/kg (p?=?0.012) after six months on gluten free diet. Random measurements of FC are not raised in children with JIA or CD. A significant elevation of FC in these groups is not explained by their diagnosis and therefore needs further investigation.
Showing items related by title, author, creator and subject.
Watson, Hunna J (2007)It is of crucial importance to identify and disseminate effective treatments for paediatric obsessive-compulsive disorder (OCD). OCD is time-consuming and distressing, and can substantially disable functioning at school, ...
Desire to have children among people living with HIV in post-conflict Northern Uganda : a mixed methods studyNattabi, Barbara (2012)Millions of people continue to contract the HIV virus every year, includingthousands of children in Sub-Saharan Africa who mainly contract HIV throughmother-to-child transmission (MTCT). Several factors are responsible ...
Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injectionsRead, F.; Boyd, Roslyn; Barber, L. (2017)© 2017 Background Serial lower limb intramuscular Botulinum toxin-A (BoNT-A) injections are administered to children with bilateral spastic cerebral palsy (BCP) to reduce spasticity, improve walking and functional mobility, ...